Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Christopher Bolden, PhD
Cancer Biology
Xavier University
Levon Bostanian PhD
Translational Oncology
Xavier University
J. Quincy Brown PhD
Translational Oncology
Tulane University School of Medicine
Justin Brown PhD
Population Sciences
Pennington Biomedical Research Center
Bridgette Collins-Burow MD PhD
Translational Oncology
Tulane University School of Medicine
Matthew E. Burow PhD
Cancer Biology
Tulane University School of Medicine
Kevin Callison PhD
Population Sciences
Tulane University School of Medicine
Jennifer Cameron PhD
Genes X Environment
LSU Health - New Orleans
Tara Castellano, MD
Translational Oncology
LSU Health - New Orleans